Check out our most popular compounded medications! Get Started
This Metronidazole 20 mg/g, Misoprostol 24 µg/g, and Pentoxifylline 50 mg/g topical ointment is a semi-solid formulation dispensed in a tube, designed for external application to the skin. It features a greasy or oily base that facilitates the delivery of active ingredients directly to the affected area, ensuring localized treatment.
This ointment is specifically formulated to treat conditions such as skin inflammation, infections, and wound healing. The combination of Metronidazole, Misoprostol, and Pentoxifylline works synergistically to reduce inflammation, combat infection, and promote tissue repair.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
When using the Metronidazole 20 mg/g/Misoprostol 24 µg/g/Pentoxifylline 50 mg/g topical ointment, it is important to consider potential drug interactions that may affect the efficacy and safety of the treatment. This formulation is designed for external application to the skin and is typically used for conditions such as skin inflammation, infections, or wound healing. Each active ingredient in this ointment has its own interaction profile, which should be carefully reviewed by both patients and prescribers.
Metronidazole, an antibiotic and antiprotozoal agent, is primarily used to treat infections caused by anaerobic bacteria and certain parasites. Although systemic absorption from topical application is generally low, it is still possible for metronidazole to interact with other medications. Notably, metronidazole can potentiate the effects of oral anticoagulants like warfarin, leading to an increased risk of bleeding. Patients using anticoagulants should be monitored closely, and dosage adjustments may be necessary. Additionally, metronidazole can interact with alcohol, causing a disulfiram-like reaction characterized by flushing, nausea, vomiting, and tachycardia. Patients should be advised to avoid alcohol consumption during treatment and for at least 48 hours after discontinuation.
Misoprostol, a prostaglandin E1 analog, is used for its anti-inflammatory and cytoprotective properties. While systemic absorption from topical application is minimal, caution is advised when used concurrently with other medications that may affect prostaglandin pathways, such as NSAIDs or corticosteroids. These interactions could potentially alter the therapeutic effects of misoprostol or the co-administered drugs. Additionally, misoprostol is contraindicated in pregnant women due to its uterotonic effects, which can lead to miscarriage. Women of childbearing potential should use effective contraception during treatment and consult their healthcare provider if pregnancy is planned or suspected.
Pentoxifylline, a methylxanthine derivative, improves blood flow and has anti-inflammatory properties. It is primarily metabolized by the liver, and interactions with other medications that affect hepatic enzyme activity should be considered. Concurrent use with anticoagulants or antiplatelet agents may increase the risk of bleeding, necessitating careful monitoring and possible dosage adjustments. Additionally, pentoxifylline may interact with theophylline, leading to increased theophylline levels and potential toxicity. Patients should inform their healthcare provider of all medications they are taking to assess the risk of interactions.
Overall, while the risk of systemic interactions is reduced with topical application, it is crucial for patients and prescribers to be aware of these potential interactions. Patients should provide a complete list of their current medications, including over-the-counter drugs and supplements, to their healthcare provider. Prescribers should evaluate the potential for interactions and adjust treatment plans accordingly. If you have any questions or concerns about drug interactions with this formulation, please reach out to us for further assistance.
This topical ointment formulation combines Metronidazole, Misoprostol, and Pentoxifylline to provide a multifaceted approach to treating skin conditions such as inflammation, infections, and aiding in wound healing. Each component plays a distinct role in the therapeutic process, working synergistically to enhance the overall efficacy of the treatment.
When applied topically, Metronidazole works by entering the microbial cells and disrupting their DNA synthesis, leading to cell death. This action helps in reducing the bacterial load on the skin, thereby controlling infection and preventing further spread. It is particularly useful in treating skin conditions that are exacerbated by bacterial infections, such as rosacea or infected wounds.
Misoprostol, present at 24 µg/g, is a synthetic prostaglandin E1 analog. It plays a crucial role in promoting wound healing and reducing inflammation. Misoprostol works by mimicking the action of natural prostaglandins, which are compounds in the body that help regulate inflammation and protect the gastric lining. Additionally, its anti-inflammatory properties help in reducing redness, swelling, and discomfort associated with skin lesions.
Pentoxifylline, included at 50 mg/g, is a methylxanthine derivative that improves microcirculation and tissue oxygenation. It works by decreasing blood viscosity and improving red blood cell flexibility, which enhances blood flow to the affected areas. This increased circulation aids in delivering essential nutrients and oxygen to the skin, promoting faster healing and recovery. Pentoxifylline also exhibits anti-inflammatory effects, further contributing to the reduction of swelling and pain in inflamed skin conditions.
The semi-solid ointment base of this formulation is designed to provide a greasy or oily medium that facilitates the penetration of these active ingredients into the skin. This base not only aids in the delivery of the medication but also forms a protective barrier over the skin, helping to retain moisture and prevent further irritation or infection. The ointment is dispensed in a convenient tube, allowing for easy and precise application to the affected areas.
This combination of Metronidazole, Misoprostol, and Pentoxifylline in a topical ointment form offers a comprehensive treatment option for patients suffering from various skin conditions. By addressing infection, inflammation, and impaired circulation, this formulation supports the body's natural healing processes and provides relief from symptoms. For prescribers, this ointment represents a versatile tool in managing complex skin conditions that require a multifaceted therapeutic approach.
If you have any questions or need further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to assist you with any inquiries you may have.
Metronidazole is an antibiotic that helps to reduce bacteria and inflammation on the skin. It is commonly used to treat skin infections and conditions such as rosacea or acne.
Misoprostol is a prostaglandin analog that can help promote healing and reduce inflammation. It is included in the ointment to aid in the repair of damaged skin and enhance the healing process.
Pentoxifylline is a vasodilator that improves blood flow and oxygen delivery to the affected area. This can help reduce inflammation and promote faster healing of the skin.
Apply a thin layer of the ointment to the affected area of the skin, usually once or twice daily, or as directed by your healthcare provider. Make sure to wash your hands before and after application.
It is important to consult with a healthcare provider before using this ointment on open wounds, as it may not be suitable for all types of wounds or skin conditions.
Some users may experience mild side effects such as skin irritation, redness, or itching. If you experience severe side effects or an allergic reaction, discontinue use and seek medical attention.
Consult with your healthcare provider before using this ointment if you are pregnant or breastfeeding, as some components may not be recommended during these periods.
Before using this ointment with other topical medications, consult your healthcare provider to avoid potential interactions or reduced effectiveness.
Store the ointment at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
If you miss a dose, apply it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not apply extra to make up for a missed dose.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
